Skip to content

Agenda

7:00 – 7:30 am Breakfast Breakout Check-in & Networking Breakfast
Hosted by:
Aerie
7:30 – 8:15 am Breakout Sessions
MIGS

Moderator:
Steven Vold, MD

Participants:
John Berdahl, MD
Chris Calcaterra, Chief Commercial Officer – Glaukos
Richard Lewis, MD

Refractive Correction – Corneal & Intraocular

Moderator:
Vance Thompson, MD

Participants:
Eric Donnenfeld, MD
Rajesh K. Rajpal, MD, Chief Medical Officer – Avedro
John Vukich, MD

Breakfast with the FDA

Moderator:
Emmett T. Cunningham Jr., MD, PhD, MPH, Partner – Clarus Ventures

Participants:
Wiley Chambers, Deputy Director, Division of Transplant & Ophthalmology Products Center for Drug Evaluation & Research – FDA
Malvina B. Eydelman, MD, Director, Division of Ophthalmic & Ear, Nose & Throat Devices – FDA

Dry Eye

Moderator:
Edward Holland, MD

Participants:
Michael Ackermann, PhD, VP, Neurostimulation – Allergan
Kim Brazzell, PhD, Chief Medical Officer – Kala Pharmaceuticals
John Sheppard, MD

Innovative Alternatives to Drops

Moderator:
Richard Lindstrom, MD

Participants:
Mark Baum, CEO – Imprimis Pharmaceuticals
Adnan Butt, Biotechnology Analyst – RBC Capital Markets
Eugene de Juan, MD, Founder & Vice Chairman – ForSight Labs
Amar Sawhney, PhD, President, CEO & Chairman – Ocular Therapeutix
Hartaj Singh, Analyst – BTIG

8:00 – 8:45 am General Attendance Check-in & Networking Breakfast
8:45 – 9:00 am Summit Kick off with Ophthalmology Innovation Cycle & Financing Update
William J. Link, PhD, Managing Director – Versant Ventures
9:00 – 10:05 am Ophthalmology Innovation Showcase
Moderators:
Susan Benton, Head, Ophthalmics Business Development – Shire
Jerry St. Peter, VP & Head, Ophthalmic Business – Sun Pharmaceutical Industries

Company Presentations
  • 9:00 – 9:05 | PowerVision | Barry Cheskin, President, CEO & Co-Founder
  • 9:05 – 9:10 | Refocus Group | Mike Judy, CEO
  • 9:10 – 9:15 | ReVision Optics | John Kilcoyne, President & CEO
  • 9:15 – 9:20 | Encore Vision | Bill Burns, President & CEO
  • 9:20 – 9:25 | ClarVista Medical | Paul McLean, CEO
  • 9:25 – 9:30 | Mynosys Cellular Devices | John Hendrick, President & CEO
  • 9:30 – 9:35 | International Biomedical Devices | Mark Packer, MD, Chief Medical Officer
  • 9:35 – 9:40 | Cassini | Mark Packer, MD, Chief Medical Officer
  • 9:40 – 9:45 | TearScience | Joseph Boorady, President & CEO
  • 9:45 – 9:50 | Aerie Pharmaceuticals | Tom Mitro, President & COO
  • 9:50 – 9:55 | ForSight VISION5 | James Brandt, MD, Principal Investigator
  • 9:55 – 10:00 | Ocular Therapeutix | Amar Sawhney, PhD, President, CEO & Chairman
  • 10:00 – 10:05 | Avedro | Rajesh K. Rajpal, MD, Chief Medical Officer
10:05 – 10:30 am Morning Networking & Refreshment Break
10:30 – 11:20 am Diagnostics-Impact on the Premium Channel
Market Overview

Richard Lindstrom, MD

Company Presentations
Panel Discussion

Moderator:
Richard Lindstrom, MD

Participants:
Tom Frinzi, President – AMO, SVP – Abbott Laboratories
Dave Harmon, President – Market Scope
Warren Hill, MD
Ludwin Monz, PhD, President & CEO – Carl Zeiss Meditec AG
Jay Pepose, MD, PhD
Vance Thompson, MD

11:20 am – 12:00 pm Spotlight on the Premium Channel
Market Overview

Elizabeth Yeu, MD

Company Presentations
Panel Discussion

Moderator:
Elizabeth Yeu, MD

Participants:
David Chang, MD
Eric Donnenfeld, MD
Sherman Reeves, MD, MPH
Denise Visco, MD

12:00 pm Networking Lunch Commences
Hosted by:
Alcon
12:50 – 1:15 pm OIS LIFETIME INNOVATOR AWARD
Recipient:
Roger Steinert, MD

Interviewed By:
Stephen Lane, MD

1:15 pm Lunch Concludes
1:15 – 1:55 pm WTF@OIS: What’s the Future @OIS?
Unconventional innovations challenging conventional wisdom

Co-Moderators:
Gilbert H. Kliman, MD, Managing Director – InterWest Partners
Stephen Slade, MD

Company Presentations
1:55 – 2:25 pm Afternoon Networking & Refreshment Break
2:25 – 3:05 pm Spotlight on MIGS
MIGS is Growing Up: A Market Assessment

Ike Ahmed, MD

Company Presentations
  • Taking a MIGS company public: Glaukos | Chris Calcaterra, Chief Commercial Officer
  • Acquiring a MIGS company: Allergan | Dave LeCause, VP, US Eye Care
  • FDA and MIGS evolving guidance: Transcend | Sean Ianchulev, MD, MPH, Chief Medical Officer
  • Differentiating MIGS devices and the cataract surgeon: Ivantis | Dave Van Meter, President & CEO
  • Glaucoma device development beyond MIGS: InnFocus | Russ Trenary, President & CEO
Panel Discussion

Moderator:
Ike Ahmed, MD

Participants:
Robert Cionni, MD
Richard Lewis, MD
Jai G. Parekh, MD, MBA

3:05 – 3:55 pm Masters of the Universe
Moderator:
Jim Mazzo, Executive Chairman & CEO – AcuFocus

Participants:
Mike Ball, CEO – Alcon
Tom Frinzi, President – AMO, SVP – Abbott Laboratories
William J. Link, PhD, Managing Director – Versant Ventures
Ashley McEvoy, Company Group Chairman – Johnson & Johnson Vision Care
William Meury, EVP, President Branded Pharma – Allergan
Ludwin Monz, PhD, President & CEO – Carl Zeiss Meditec AG
Calvin Roberts, MD, SVP & Chief Medical Officer – Bausch + Lomb

3:55 – 4:00 pm Closing Remarks
Gilbert H. Kliman, MD, Managing Director – InterWest Partners
4:00 – 5:00 pm Networking Reception
Hosted by:
Abbott
Scroll To Top